A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Public ClinicalTrials.gov record NCT05364931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Cotadutide in Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Study identification
- NCT ID
- NCT05364931
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 54 participants
Conditions and interventions
Interventions
- Cotadutide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 13, 2022
- Primary completion
- Apr 18, 2024
- Completion
- Apr 18, 2024
- Last update posted
- Sep 2, 2025
2022 – 2024
United States locations
- U.S. sites
- 29
- U.S. states
- 13
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | 85712 | — |
| Research Site | Canoga Park | California | 91303 | — |
| Research Site | Gilroy | California | 95020 | — |
| Research Site | Sacramento | California | 95821 | — |
| Research Site | Englewood | Colorado | 80113 | — |
| Research Site | Bradenton | Florida | 34208 | — |
| Research Site | Homestead | Florida | 33032 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Miami | Florida | 33175 | — |
| Research Site | Miami | Florida | 33176 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Munster | Indiana | 46321 | — |
| Research Site | Houma | Louisiana | 70363 | — |
| Research Site | Marrero | Louisiana | 70006 | — |
| Research Site | Marrero | Louisiana | 70072 | — |
| Research Site | Shreveport | Louisiana | 71105 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Las Vegas | Nevada | 89104 | — |
| Research Site | Las Vegas | Nevada | 89109 | — |
| Research Site | Lawrence | New Jersey | 08648 | — |
| Research Site | Warren Township | New Jersey | 07059 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Chattanooga | Tennessee | 37421 | — |
| Research Site | Arlington | Texas | 76012 | — |
| Research Site | Austin | Texas | 78745 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Lewisville | Texas | 75057 | — |
| Research Site | San Antonio | Texas | 78215 | — |
| Research Site | Ogden | Utah | 84403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05364931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05364931 live on ClinicalTrials.gov.